Form 4 for CVS CVS Health
Accepted 2026-04-02 16:52:59 ET · period of report 2026-03-31 · accession 0000064803-26-000038 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-02 16:52 | 2026-03-31 | CVS | Joyner J. David | Pres, CEO, COB, Dir | A - Grant | $71.82 | +86.3K | 160.9K | +116% | +$6.20M | |
| 2026-04-02 16:52 | 2026-04-01 | CVS | Joyner J. David | Pres, CEO, COB, Dir | F - Tax | $72.49 | -8,029 | 70.3K | -10% | -$582.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock (RSUs) | 2026-03-31 | A | A | 86,326 | $71.82 | 160,860 | D | — | — | (F1) Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027. |
| 2 | Common | Common Stock | 2026-04-01 | F | D | 8,029 | $72.49 | 70,349 | D | — | — | (F2) Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units. |